Q3 above estimates: Sales/EBITDA/PAT grew 18%/30%/33%. EBITDA margin improved 200 bps to 20.8%, as higher input costs (up 410 bps) was offset by reduced staff costs (down 200 bps on increased share of outsourced manufacturing)